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Abstract We propose a histopathological classiWcation
system for hippocampal cell loss in patients suVering
from mesial temporal lobe epilepsies (MTLE). One
hundred and seventy-eight surgically resected specimens
were microscopically examined with respect to neuronal
cell loss in hippocampal subWelds CA1–CA4 and den-
tate gyrus. Five distinct patterns were recognized within
a consecutive cohort of anatomically well-preserved sur-
gical specimens. The Wrst group comprised hippocampi
with neuronal cell densities not signiWcantly diVerent
from age matched autopsy controls [no mesial temporal
sclerosis (no MTS); n = 34, 19%]. A classical pattern
with severe cell loss in CA1 and moderate neuronal loss
in all other subWelds excluding CA2 was observed in 33
cases (19%), whereas the vast majority of cases showed
extensive neuronal cell loss in all hippocampal subWelds
(n = 94, 53%). Due to considerable similarities of neuro-
nal cell loss patterns and clinical histories, we designated
these two groups as MTS type 1a and 1b, respectively.
We further distinguished two atypical variants charac-
terized either by severe neuronal loss restricted to sector
CA1 (MTS type 2; n = 10, 6%) or to the hilar region
(MTS type 3, n = 7, 4%). Correlation with clinical data
pointed to an early age of initial precipitating injury
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(IPI < 3 years) as important predictor of hippocampal
pathology, i.e. MTS type 1a and 1b. In MTS type 2, IPIs
were documented at a later age (mean 6 years), whereas
in MTS type 3 and normal appearing hippocampus (no
MTS) the Wrst event appeared beyond the age of 13 and
16 years, respectively. In addition, postsurgical outcome
was signiWcantly worse in atypical MTS, especially MTS
type 3 with only 28% of patients having seizure relief
after 1-year follow-up period, compared to successful
seizure control in MTS types 1a and 1b (72 and 73%).
Our classiWcation system appears suitable for stratifying
the clinically heterogeneous group of MTLE patients
also with respect to postsurgical outcome studies.
Introduction
Mesial temporal sclerosis (MTS) is the most recog-
nized Wnding in drug resistant, chronic temporal lobe
epilepsies [5]. Tailored resection strategies including
selective amygdala-hippocampectomy are established
treatment modalities and oVer a favourable outcome
with up to 80% postoperative seizure freedom within
the Wrst 2 years [1, 2, 14, 17, 45, 47]. Clinical studies
assume mesial temporal lobe epilepsy, however, as a
heterogeneous entity with diVerent etiologies and clini-
cal histories [14, 17, 39, 46]. Hence, neuropathological
investigations described diVerent patterns of neuronal
cell loss within hippocampal subWelds and adjacent
temporal lobe structures of surgical specimens [10, 27,
32, 34, 48] or autopsy brains obtained from patients
suVering from chronic epilepsies [22, 28, 38, 44].
A reliable neuropathological classiWcation system will
be most helpful to separate distinct pathological sub-
groups and to better predict postsurgical outcome. A Wrst
systematic attempt to semi-quantitatively estimate hippo-
campal cell loss was published in 1992 by Wyler [48],
referring to percentages of pyramidal cell loss within iden-
tiWed hippocampal subWelds CA1–CA4. The Wyler-Score
includes Wve grades, identifying classic and severe AHS
as the most frequent pathologies. This grading system is
practical in use, but thresholds were chosen arbitrarily
and do not consider clinical histories. We applied comput-
erized cluster analysis to deWne distinct neuropathological
patterns of MTS. Neuronal cell densities were semi-quan-
titatively determined in anatomically conWrmed hippo-
campal subWelds and the dentate gyrus in a consecutive
series of 178 surgically well-preserved hippocampus speci-
mens and subsequently used for cluster analysis.
A further intriguing issue is the evaluation of deter-
mining factors on hippocampal pathology patterns and
postsurgical outcome. Earlier studies provide evidence
to time related factors such as epilepsy duration [17],
age at epilepsy onset and the presence of an early
preceding event, especially complex and prolonged
febrile seizures [3, 9, 24, 26, 34, 45] as likely pathogenic
mechanisms inXuencing the degree of MTS. Seizure
frequency and severity are other parameters to be sys-
tematically revisited. A reliable classiWcation system
would be of paramount importance and should rely,
therefore, on a systematic histopathological examina-
tion and the patients’ clinical examination, especially
postoperative seizure outcome.
Materials and methods
Subjects
Hippocampal specimens were obtained in the frame-
work of a multi-centre study including four German
centres for epilepsy surgery (University Medical Schools
of Berlin, Bonn, Erlangen, and Freiburg).
During a time period from 2002 to 2005, 237 Patients
were reported by the four centres to the German Epi-
lepsy Surgery Reference Center. Of these, 59 had to be
excluded due to incomplete preservation of the entire
hippocampal structure. Altogether, 178 patients could
be included [87 men (49%), 91 women (51%); mean
age 38.4 § 13.0 years; 93 (52%) with left- and 85 (48%)
with right-sided resections]. Eight additional hippocam-
pal specimens obtained from neurologically healthy
autopsies (mean age 49 § 6.8 years) served as controls.
All patients underwent presurgical evaluation includ-
ing Video-EEG monitoring, high-resolution MR imag-
ing and neuropsychological testing [8,  20]. Temporal
lobe epilepsy refractory to medication with a mesio-
temporal focus was diagnosed in all cases. Surgical
strategy comprised diVerent subtypes of “tailored”
anterior temporal resections including the hippocam-
pal complex, i.e. standard anterior temporal lobectomy
with amygdalo-hippocampectomy, polar temporal
resection plus hippocampectomy, and “selective” amy-
gdalo-hippocampectomy [8]. Informed consent was
given from all patients included in our study for further
scientiWc investigations.
Tissue preparation
For histopathological examination, hippocampal en
bloc resections were dissected into 5-mm-thick slices
along the anterior–posterior axis. Tissue samples from
the mid hippocampal body [11] were chosen for this
study,  Wxed overnight in 4% formalin and routinely
processed into liquid paraYn. All specimens were cut
at 4 m with a microtome (Microm, Heidelberg),Acta Neuropathol (2007) 113:235–244 237
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stretched in water at 40°C and mounted on slides
coated with silane (Langenbrinck; Emmendingen, Ger-
many). The slides were air-dried in an incubator at
37°C overnight, deparaYned in descending alcohol
concentration and stained with hematoxylin and eosin
(HE). Hippocampal pyramidal neurons and granule
cells of the dentate gyrus were speciWcally detected
using immunohistochemistry for the neuronal nuclear
antigen NeuN (A60, Chemicon, Temecula, USA, dilu-
tion 1:1,000, pre-treated with microwave) and an auto-
mated staining apparatus using the streptavidin–biotin
method (Ventana; Strasbourg, France) and 3,3-diam-
inobenzidine as chromogen as well as hematoxylin
counterstaining. Due to less reliable NeuN staining in
post-mortem tissue, neurons of autopsy controls were
counted on HE-stained sections. To evaluate the
reproducibility of both staining procedures, we repeti-
tively compared NeuN and HE-stained surgical speci-
mens and obtained similar neuronal densities (with
standard deviations been slightly increased in the HE
group) and identical MTS typing.
Neuronal cell counts
All tissue specimens were microscopically examined by
the German Neuropathological Reference Center for
Epilepsy Surgery in Erlangen. Semi-quantitative mea-
surements of neuronal cell numbers were performed
with a microcomputer imaging system (ColorView II
CCD camera, AnalySIS imaging software, Stuttgart,
Germany) equipped to a BX51 microscope (Olympus,
Japan).
Immunohistochemically stained neuronal cell bodies
(NeuN) were tagged on the computer screen and man-
ually counted separately within hippocampal sectors
CA1, CA2, CA3 and CA4 in four randomly placed
visual Welds at 200£ objective magniWcation, represent-
ing 62,500 m² (0.0625 mm²). Granule cells of the den-
tate gyrus were separately counted at 400£ objective
magniWcation in 20 randomly placed visual Welds, rep-
resenting 0.01 mm². For all neuronal cell counts the
mean number of neurons/mm2 was calculated and val-
ues transformed into z-scores (see Statistical analysis).
Statistical analysis
For statistical evaluation SPSS 12.0G for Windows,
Version 12.01 was used. Statistical analysis was calcu-
lated using z-scores. The z-score represents, in stan-
dard deviation units, the amount a score deviates from
the mean of the population from which the score is
drawn [z = (score ¡ mean of the population)/standard
deviation of the population]. The mean of the normal
curve is set at zero and the standard deviation unit has
a value of one. This statistical calculation is particularly
useful when comparing diVerent anatomical compart-
ments of varying cellularity, i.e. pyramidal cell versus
granule cell layers.
Cluster analysis was used to identify distinct sub-
groups of neuropathological patterns. The analysis was
based on Euclidean distance coeYcients for all possible
pairs of standardized cell loss (z-scores) in the diVerent
hippocampal compartments. We included all hippo-
campal subWelds (CA1–CA4) and dentate gyrus into
the analysis. The classiWcation of cases into clusters was
iteratively updated. After assignment of cases according
to the cluster analysis, in a further step Discriminate
Analysis was used to derive the classiWcation rule. This
linear equation allows the classiWcation of new cases.
Variance analysis with one-way ANOVA was per-
formed to analyse inXuence of clinical parameters on
distinct clusters. A respective software program to cal-
culate MTS clusters from individual hippocampal cell
counts will be made available on the internet platform
of the neuropathological reference centre for epilepsy
surgery upon request (http://www.epilepsie-register.de).
Results
Cluster analysis
Five distinct pathology patterns were recognized using
cluster analysis (Fig. 1): no MTS = “no hippocampal
cell loss” (n = 34, 19%), MTS type 1a = ”classic hippo-
campal sclerosis” (n = 33, 19%), MTS type 1b =
“severe hippocampal sclerosis” (n = 94, 53%), MTS
type 2 = “CA1 sclerosis” (n = 10, 6%), and MTS type
3 = “end folium sclerosis” (n =7 ,  4 % ) .
Within the Wrst cohort of surgical specimens (no
MTS), variation of mean neuronal cell densities were
within the Wrst standard deviation as compared to
autopsy control values and, therefore, deWned as nor-
mal (Fig. 2a). Compared to controls, mean neuronal
densities for all hippocampal sectors ranged from 93.6
to 103.4% (Table 1). Twelve (35.3%) out of 34 patients
of the “no MTS” group presented with a focal lesion in
the vicinity of the hippocampus, most frequently a low
grade glioneuronal tumour such as ganglioglioma or
dysembryoplastic neuroepithelial tumour in seven
cases, followed by cortical dysplasia in four cases and
one case with a cavernoma. In contrast, within the
MTS groups focal lesions were rare and equally dis-
tributed, including four cases with low-grade glioneu-
ronal tumours, one case with a glio-mesodermal scar
after trauma and one case with a former encephalitis.238 Acta Neuropathol (2007) 113:235–244
123
In MTS type 1a and 1b, the CA1 segment was most
severely aVected (minimum neuronal loss within the
sixfold standard deviation). Cluster analysis revealed,
however, signiWcant diVerences between these two
groups with respect to neuronal cell loss in hippocam-
pal subWelds CA2, CA3 and CA4. In MTS type 1a
(Fig.  1), neuronal cell densities revealed a mean loss
of 30–40% (remaining neuronal densities in CA2 =
68.7 § 16.1%, in CA3 = 70.4 § 15.9% and in CA4 =
61.5 § 28.8%, Table 1), and resembled those deWned
earlier as classic hippocampal sclerosis [22,  38,  48]
(Fig. 2d). In addition, the dentate gyrus was aVected by
53.8 § 9.7% granule cells loss. In contrast, MTS type
1b showed severe neuronal loss in all hippocampal sub-
Welds (minimum fourth standard deviation, Figs. 1, 2e),
with remaining neuronal densities ranging from 38.4 §
12.1% in DG, 14.8 § 12.3% in CA4, 14.9 § 9.3% in
CA1 and 28.0 § 14.5% in CA3 (Table 1) as compared
to controls. Furthermore the hippocampal subWeld
CA2 was aVected more severely with a mean neuronal
density of 51.0 § 17.7%.
MTS type 2 included ten cases with severe cell
loss almost restricted to CA1 (sixfold standard devi-
ation; Fig. 1, mean cell density 21.8 § 9.1%, Table 1)
and only mild decrease in CA2–CA4 (Wrst to second
standard deviation, Fig. 1, mean cell densities in
CA2 = 82.2 § 10.5%, in CA3 = 82.2 § 22.5% and in
CA4 = 75.7 § 25.7%, Table 1). Due to the restricted
pathology pattern observed in hippocampal subWeld
CA1, we considered this group as an atypical entity
similar to that described earlier by de Lanerolle and
coworkers [10] (Fig. 2c).
In contrast to the latter, MTS type 3 showed signiWcant
cell loss within the second standard deviation in all hip-
pocampal subWelds except for CA1 (Fig. 1). Neuronal
cell loss was mainly decreased in hippocampal subWeld
CA4 (55.3 § 20.5%) and the dentate gyrus (65.5 § 11.6),
whereas CA3 (70.3 § 14.7%), CA2 (74.8 § 26.3%) and
CA1 (80.6 § 16.8%) were only moderately aVected
(Table 1). According to the main pathology within the
hilar region and in DG, this group was considered as
end folium sclerosis [22, 48] (Fig. 2b).
Clinico-pathological correlation
Pathology clusters were correlated with a data set of
previously reported clinical histories, which may have
signiWcant impact on the degree of hippocampal cell
loss. Age at surgery, age at epilepsy onset, gender, side
of resection and anatomical location of hippocampal
specimens along the anterior–posterior axis which was
used for histopathological analysis (according to
Duvernoy 2005) were not diVerent between the Wve
MTS clusters. In addition, seizure frequency and esti-
mated lifetime seizures did not have any inXuence on
severity of hippocampal pathology. Intriguingly, anal-
ysis of variance revealed an inXuence of epilepsy dura-
tion with neuropathological patterns of MTS. Normal
appearing hippocampus and MTS type 3 revealed
shorter epilepsy duration compared to MTS type 1a,
1b and 2 (as characterized by severe CA1-pathology
and diVerent degrees of neuronal loss within the
remaining hippocampal subWelds and dentate gyrus;
see Table 2).
In 171 cases, we obtained suYcient data with respect to
presence/absence of initial precipitating injuries (IPIs)
before epilepsy onset. Overall, 67 (39.2%) patients
presented with an IPI before epilepsy onset, 38
(56.7%) of them experienced prolonged and complex
febrile seizures. Other IPIs included encephalitis
(n = 15, 22.4%), head trauma (n = 7, 10.4%), birth
trauma (n = 4, 6.0%) or intracerebral bleeding (n =3 ,
4.5%). Occurrence of an IPI was similarly distrib-
uted within MTS type 1a, type 1b and type 2 (severe
Fig. 1 Cluster analysis of histopathological Wndings in MTS.
Semi-quantitative cell measurements were transformed into z-
scores and revealed Wve distinct patterns of hippocampal pathol-
ogy: no MTS = normal hippocampus with cell loss within Wrst
standard deviation compared to controls (z-score = 0); MTS type
1a = classic hippocampal sclerosis with severe loss in CA1 and
moderate loss in remaining sectors; MTS type 1b = severe hippo-
campal sclerosis aVecting all hippocampal sectors; MTS type
2 = severe loss in CA1 and only mild pathology within remaining
sectors (i.e. CA1-sclerosis); MTS type 3 = end folium sclerosis
with moderate cell loss in all sectors with the exception of CA1.
Open circles identify individual patients, which escaped the group
determining patterns. z-CA1-CA4 = z-score of CA1-CA4 Weld of
cornu ammonis; z-DG = z-score of dentate gyrusActa Neuropathol (2007) 113:235–244 239
123
CA1-pathology) ranging from 43 to 50% (Table 3). In
contrast, only three patients with an otherwise normal
hippocampus (no MTS) experienced IPI (9.4%) and in
end folium sclerosis no preceding event occurred. In
the latter two groups, IPI excluded febrile seizures,
while one-third of patients with MTS type 1a, type 1b
and type 2 presented with febrile seizures in their early
childhood (P =0 . 0 0 4 ) .
Precipitating injuries diVered in mean age of onset
(P < 0.001). Earliest events were birth trauma and
febrile seizures, which occurred before the age of
4 years (mean 1.3 § 0.7 years), followed by encepha-
litis (mean 4.9 § 7.7 years), intracerebral bleeding
(mean 12.0 § 18.2 years) and head trauma (mean
13.3 § 15.4 years). Detailed analysis of IPIs within
diVerent pathology groups revealed occurrence of
early events such as birth trauma and febrile seizures
primarily in MTS type 2 (three out of four events,
75%), MTS type 1a (11 out of 14 events, 79%) and
MTS type 1b (28 out of 46 events, 61%). In patients
with no MTS, only three patients presented late onset
events such as head trauma, encephalitis and intrace-
rebral bleeding. Analysis of variance conWrmed the
inXuence of age at initial precipitating injury (IPI, e.g.
febrile seizure, birth trauma, encephalitis or Wrst
seizure in the absence of precipitating injury). In
patients with MTS type 1a, IPI occurred at age
2 years, in MTS type 1b at age 3 years, followed by
MTS type 2 at a median age of 6 years and a late
event in MTS type 3 (median = 13 years) as well as
normal appearing hippocampus (no MTS, median =
16 years).
Fig. 2 Histopathological Wnd-
ings in MTS patients. a no 
MTS, b MTS type 3 (end foli-
um sclerosis), c MTS type 2 
(CA1-sclerosis), d MTS type 
1a (classic hippocampal scle-
rosis) and e MTS type 1b (se-
vere hippocampal sclerosis). 
Scale bars 1 mm. Asterisks 
index regions with predictive 
cell loss patterns240 Acta Neuropathol (2007) 113:235–244
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Six months outcome was available for 171 patients
(Table 4). One hundred and thirty-Wve (79%)
patients became seizure free (Engel 1), 18 (11%)
patients showed rare disabling seizures (Engel 2), 14
(8%) patients had a worthwhile improvement (Engel 3)
and four (2%) patients did not change (Engel 4). Best
outcome occurred in patients with MTS type 1a (86%
seizure free) and MTS type 1b (85% seizure free), fol-
lowed by patients with no MTS (71% seizure free). In
Table 1 Semi-quantitative examination of surgical hippocampus
specimens
Neuronal cell densities within hippocampal subWelds (CA1-CA4)
and dentate gyrus (DG) expressed as percentages of autopsy con-
trol values (data not shown). Bold values highlight group identi-
fying determinants of neuronal cell loss, i.e. CA1 in MTS type 2,
and CA4 in MTS type 3
n number of cases, SD standard deviation, MTS mesial temporal
sclerosis
Pathology CA1 CA2 CA3 CA4 DG
No MTS Mean 100.3 95.2 103.4 93.6 89.6
n = 34 SD 19.9 14.6 19.4 15.9 12.7
MTS type 1a Mean 19.0 68.7 70.4 61.5 46.2
n = 33 SD 8.3 16.1 15.9 28.8 9.7
MTS type 1b Mean 14.9 51 28 14.8 38.4
n = 94 SD 9.3 17.7 14.5 12.3 12.1
MTS type 2 Mean 21.8 82.2 82.2 75.7 80.9
n = 10 SD 9.1 10.5 22.5 25.7 11.2
MTS type 3 Mean 80.6 74.8 70.3 55.3 65.5
n = 7 SD 16.8 26.3 14.7 20.5 11.6
Table 2 Correlation between histopathology and clinical histo-
ries
N = number of cases, Mean = age in years, SD = standard devia-
tion,  P-values refer to ANOVA (independent
variable = pathology patterns, dependent variables = age at the
Wrst event, latency periods between Wrst event and epilepsy onset,
and epilepsy duration; P <0 . 0 5  w a s  d e Wned as signiWcant, P-value
applies to all categories)
Pathology N Mean SD P
Age at Wrst event or seizure
No MTS 33 18.4 11.0 0.0001
MTS type 1a 33 5.9 8.9
MTS type 1b 94 9.8 12.7
MTS type 2 10 10.9 11.0
MTS type 3 7 14.0 8.7
Total 177 10.9 12.1
Latency
No MTS 33 0.0 – 0.008
MTS type 1a 33 4.4 8.5
MTS type 1b 94 5.7 9.4
MTS type 2 9 4.1 6.8
MTS type 3 7 0.0 –
Total 176 4.1 8.2
Epilepsy duration
No MTS 33 15.9 10.6 0.007
MTS type 1a 33 24.5 15.2
MTS type 1b 94 25.5 14.0
MTS type 2 9 23.2 11.4
MTS type 3 7 17.0 9.4
Total 176 23.1 13.8
Table 3 Correlation between pathology patterns and preceding
events
MTS type 1a, 1b and 2 showed similar frequencies of preceding
events, including febrile seizures (FS), whereas MTS type 3 and
patients without MTS experienced signiWcantly fewer early inju-
ries (P < 0.001)
Pathology No event Event FS Total
No MTS n 29 3 – 32
%9 0 . 6 9 . 4
MTS type 1a n 17 13 10 30
% 56.7 43.3 76.9
MTS type 1b n 47 46 25 93
% 50.5 49.5 54.3
MTS type 2 n 54 3 9
% 55.6 44.4 75
MTS type 3 n 7– – 7
%1 0 0
Total n 105 66 38 171
% 61.4 38.6 57.6 100
Table 4 Correlation between pathology patterns and postsurgi-
cal outcome
MTS types 1a and 1b gained best outcome with 85% seizure free-
dom after 6 months and 72% seizure relief after 12 months. How-
ever, atypical MTS type 3 was associated with the worst outcome.
After 12 months only two out of seven patients remained seizure
free, whereas MTS type 2 remained with a mediocre postsurgical
follow-up
Engel 1 Engel 2 Engel 3 Engel 4 Total
6 months after hippocampal resection
No MTS n 2 3 4323 2
% 71.9 12.5 9.4 6.3
MTS type 1a n 2 4 31–2 8
% 85.7 10.7 3.6 –
MTS type 1b n 8 0 86–9 4
% 85.1 8.5 6.4 –
MTS type 2 n 52211 0
% 50.0 20.0 20.0 10.0
MTS type 3 n 31217
% 42.9 14.3 28.6 14.3
Total n 135 18 14 4 171
% 78.9 10.5 8.2 2.3 100
P =0 . 0 3 1
12 months after hippocamp resection
No MTS n 1 7 4532 9
% 58.6 13.8 17.2 10.3
MTS type 1a n 1 8 3312 5
% 72.0 12.0 12.0 4.0
MTS type 1b n 62 18 4 1 85
% 72.9 21.2 4.7 1.2
MTS type 2 n 61119
% 66.7 11.1 11.1 11.1
MTS type 3 n 21317
% 28.6 14.3 42.9 14.3
Total n 105 27 16 7 155
% 67.7 17.4 10.3 4.5 100
P =0 . 0 4 0Acta Neuropathol (2007) 113:235–244 241
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patients presenting with atypical variants of MTS, sei-
zure relief was achieved only in 43% (MTS type 3) or
50% (MTS type 2) (P = 0.031, respectively). For 155
patients outcome data were already available after 1-
year follow-up period. Patients with MTS type 1a (72%
seizure free) and MTS type 1b (73% seizure free)
remained the best outcome group. In contrast, MTS
type 3 worsened with only 28% seizure relief
12 months after resection and MTS type 2 remained
with a mediocre postsurgical outcome (Table 4).
We further examined granule cell dispersion
(GCD), as microscopically determined by the recent
suggestions of the ILAE commission report [46]. The
normal anatomy of the dentate gyrus includes 6–8 lay-
ers of densely packed granule cells with sharp bound-
aries towards the pleomorphic as well as molecular
layer. GCD is characterized by broadening of the den-
tate gyrus granule cell layer composed with more than
ten layers. The boundary towards the molecular layer
is blurred and ectopic granule cells can often be recog-
nized. It is important to note that this classiWcation
should only be applied in regions without curvatures of
the dentate gyrus.
Granule cell dispersion occurred in 44% of all cases
(Table 5). GCD was abundant in MTS type 1a (52%)
and MTS type 1b (61%). In MTS type 2 (CA1-sclero-
sis) only 20% of cases presented with GCD. The latter
was not detectable in MTS type 3 (end folium sclero-
sis). It is important to note, that three patients (9%)
without hippocampal neuronal cell loss showed GCD.
Variance analysis with age at Wrst event showed that
presence of dispersion came along with an earlier dam-
aging injury (mean 8.6 § 11.0 years, median 2 years)
compared to absent dispersion (mean 12.8 § 12.7 years,
median 8 years; P = 0.022).
Discussion
Cluster analysis of microscopically examined hippo-
campal specimens obtained from surgically treated
mesial temporal lobe epilepsies (MTLE) patients
revealed  Wve distinct neuropathological subgroups.
Most intriguingly, these patterns were associated with
speciWc clinical histories and/or postsurgical outcome,
which emphasizes the suitability of our clinico-patho-
logical classiWcation system of MTS.
A substantial number of surgical specimens failed to
demonstrate speciWc neuronal cell loss (n = 34, 19%),
despite electrophysiological evidence for seizure gen-
eration within the mesial temporal lobe. This observa-
tion has been frequently reported in neuropathological
surveys of similar MTS series [5, 10, 48]. The epilepto-
genic pathomechanisms of hippocampal seizure gener-
ation remains to be further determined in this group of
patients, and we suggest a mechanism similar to the
kindling animal model. Indeed, a focal lesion (low-
grade glioneuronal tumours, cavernomas or cortical
dysplasias) adjacent to the hippocampus was identiWed
in 12 (35.3%) out of 34 patients without neuronal loss
as potential spike generator.
A small group of patients (4%) presented with seg-
mental cell loss mainly aVecting the hilar region (CA4)
and most likely correspond to end folium sclerosis
described earlier [22, 48]. We identiWed another small
cohort of patients presenting with segmental cell loss
restricted to sector CA1 (CA1-sclerosis). This latter
subgroup has also been described as a distinct entity by
an earlier neuropathological evaluation of surgical
MTS specimens (CA1 only) [10]. In our classiWcation
system, we designated these two less abundant sub-
groups as atypical variants of hippocampal sclerosis,
i.e. MTS type 3 and MTS type 2, respectively.
The vast majority of cases, however, revealed severe
cell loss of CA1 pyramidal neurons, whereas all other
segments of the hippocampus proper showed neuronal
cell loss to diVerent degrees, i.e. MTS type 1. In our
hands, only the degree of CA2 pyramidal cell loss
determined a diVerence in this cohort and we diVeren-
tiated them, therefore, into MTS type 1a (with moder-
ate CA2 cell loss) and MTS type 1b (with severe CA2
cell loss). This distinction is reasonably similar to that
described by Wyler et al. [48]. The Wyler-Score is well
established in the neuropathological work-up of MTS
and designed on the percentage of neuronal loss within
hippocampal subWelds CA1–CA4. Threshold values
are deWned either by 10% (Wyler-Score 1 = mild MTS)
or 50% of neuronal loss. ClassiWcation includes also
Wve grades (W0 = normal, W1 = mild, W2 = moderate,
W3 = classical hippocampal sclerosis and W4 = severe
Table 5 Granule cell pathology in MTS subgroups
Granule cell dispersion predominantly occurred in MTS type 1a
and 1b, whereas MTS type 3 did not reveal any granule cell layer
abnormality. Note that granule cell dispersion appeared also in
three patients without hippocampal cell loss (no MTS)
Pathology No dispersion Dispersion Total
No MTS N 31 3 34
%9 1 . 2 8 . 8
MTS type 1a N 16 17 33
% 48.5 51.5
MTS type 1b N 37 57 94
% 39.4 60.6
MTS type 2 N 82 1 0
%8 0 2 0
MTS type 3 N 7– 7
%1 0 0
Total N 99 79 178
% 55.6 44.4 100242 Acta Neuropathol (2007) 113:235–244
123
hippocampal sclerosis). End folium sclerosis was sub-
sumed into W2. However, we identiWed end folium
sclerosis and MTS predominantly restricted to CA1-
sector as clinical distinct entities with a poorer post-
operative seizure outcome. In previous investigations,
certain diYculties evolved using the Wyler-Score to
identify mild hippocampal sclerosis on the basis of 10%
neuronal loss within CA1 and CA3/CA4. Our present
analysis even identiWed 10% neuronal loss within the
Wrst standard deviation of age-matched control individ-
uals. We would suggest, therefore, categorizing these
cases into the group without histopathologically classi-
Wable MTS (no MTS). An extension and revision of the
Wyler-Score was then published by Proper [32] includ-
ing mossy Wbre sprouting. Mossy Wbre sprouting as well
as reactive gliosis are frequently associated with long-
term mesial temporal lobe epilepsy [40], and were con-
Wrmed in a variety of diVerent animal models [6, 12, 27,
29, 31, 33, 42]. Selective vulnerability of neuronal sub-
populations appears also to associate with varying
MTS patterns including somatostatin-, neuropeptide
Y- or substance P-immunoreactive interneurons [10].
However, our histopathological classiWcation system is
deliberately restricted to histopathological parameters
including pyramidal and granule cell loss, which can
be microscopically determined in any pathology labo-
ratory without further time and cost intensive or capri-
cious neuroanatomical techniques [46], i.e. Timm
staining for aberrant mossy Wbre sprouting or immuno-
histochemical analysis of interneuronal subpopula-
tions.
An intriguing challenge for any neuropathological
classiWcation system of CNS diseases is the relationship
between cellular/molecular lesion patterns and clinical
parameters as well as its predictive value for postsurgi-
cal outcome [19]. The design of our MTS classiWcation
system included, therefore, a set of clinical data, which
will be retrievable in any epilepsy centre. Hallmarks of
clinical histories in MTS patients are the time point of a
Wrst event (i.e. febrile seizures, head or birth trauma,
encephalitis, bleeding or Wrst seizure onset), epilepsy
duration and frequency of seizures [7,  18,  36]. As
reported in previous studies, seizure frequencies and
age at resection, respectively duration of epilepsy, had
no considerable inXuence on hippocampal lesion pat-
terns [9, 23]. Our cluster analysis showed similar results
(Tables 2, 3, 4). In contrast, the age of the Wrst preced-
ing event such as birth trauma, febrile seizures, head
trauma, encephalitis or Wrst seizure in the absence of a
preceding event was signiWcantly diVerent in the neuro-
pathology groups. Early events occurring under age of
7 years came along with severe neuronal loss in hippo-
campal subWeld CA1. Moreover, earlier events under
age of 3 years presented with more widespread hippo-
campal damage comprising all hippocampal sectors as
well as the dentate gyrus. Occurrence of an event or
epilepsy onset (in the absence of an event) during early
adolescence did aVect only the hilar region and spared
also other hippocampal subWelds to a greater extent.
Events occurring even at later adolescence were asso-
ciated with a rather normal appearing hippocampal
formation. Many reports emphasize the association
between initial preceding events and development of
MTS [34]. The frequent association with febrile
seizures in early childhood supports this hypothesis.
Seizures during early childhood are associated with
aberrant mossy Wbre axon connections without evi-
dence of seizure-induced cell death [25]. Moreover,
prolonged seizure discharges stimulate dentate granule
cell neurogenesis as a potential repair mechanism,
leading to aberrant connections [31]. Such alterations
may aVect normal brain development and further pro-
mote epileptogenesis, whereas seizure activity during
later adolescence may strengthen recurrent excitation
and induce excitotoxic cell damage, i.e. MTS [29, 41].
Fig. 3.
These data conWrm the earlier hypothesis that
mature hippocampal networks and neurons are resis-
tant, whereas the developing structure is more prone to
epileptogenic neurotoxicity [35]. Potential pathomecha-
Fig. 3 Experience of initial precipitating injury (IPI) correlates
with pathology patterns. Box plots identiWed an association be-
tween early onset of IPI in patients with MTS type 1a and MTS
type 1b (median age 2 or 3 years, respectively). IPI occurred later
in patients with atypical variants of MTS, i.e. types 2 and 3 (medi-
an age 6 years or 13 years, respectively). Patients without hippo-
campal cell loss experienced IPI during adolescence (median age
16 years)Acta Neuropathol (2007) 113:235–244 243
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nisms comprise disturbances during early brain devel-
opment, which are likely to reduce the pool of neuronal
adult stem cells within the hippocampal formation [4,
30]. Other possible mechanisms are increased apoptosis
or reduced proliferation during brain development as
well as glutamate excitotoxicity mediated by an imma-
ture neurotransmitter receptor phenotype of hippo-
campal cell populations including astrocytes [37]. The
occurrence of GCD in nearly half of all patients with
MTS type 1a and MTS type 1b also point to migratory
disturbances. In this respect, we observed three patients
without segmental cell loss and GCD, suggesting a mal-
formative pathomechanism to be involved [21]. Cortical
dyslamination within the temporal lobe of MTS
patients can often be demonstrated supporting a more
extensive developmental impairment in at least a pro-
portion of MTS cases [15, 43].
The new MTS classiWcation system allows some
prediction of postsurgical outcome. In our large cohort
of TLE patients, the overall 1-year outcome revealed
a rate of 68% seizure freedom, which is in the well-
recognized range of earlier reports [2, 8, 13, 16, 17].
The best outcome was achieved, however, in patients
presenting with MTS type 1a and MTS type 1b (>85%
seizure freedom), whereas only 28% of patients with
atypical MTS pattern type 3 became seizure free. Not-
withstanding, TLE patients without hippocampal neu-
ronal loss have also a proven beneWt from epilepsy
surgery.
In conclusion, cluster analysis identiWed clinically
and neuropathologically distinct patterns of hippocam-
pal pathology. This classiWcation system may be helpful
to further study clinical determinants, i.e. psycho-phys-
iological outcome of memory and learning perfor-
mance, which is also diVerentially compromised in
TLE patients undergoing tailored neurosurgical resec-
tions. Molecular-biological and electro-physiological
eVorts to distinguish MTS related pathomechanisms
are likely to beneWt from a systematic classiWcation of
MTS specimens and build an important basis to better
understand the various MTS syndromes [46].
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